| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0092 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0077 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |